As of 2026-10-14, the Fair Value of Rapid Dose Therapeutics Corp (DOSE.CN) is -0.12 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.10 CAD, the upside of Rapid Dose Therapeutics Corp is -215.03%.
With the market price of 0.10 CAD and our fair value calculation, Rapid Dose Therapeutics Corp (DOSE.CN) is not a good investment. Investing in DOSE.CN stocks now will result in a potential loss of 215.03%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2022-02-28 | 2023-02-28 | 2024-02-29 | 2025-02-28 | 2026-02-28 | 5Y Avg | |
| Net income | -8.49 | -3.81 | -4.31 | -5.40 | -3.39 | -5.08 |
| YoY growth | -370.15% | 55.11% | -13.03% | -25.49% | 37.28% | -63.26% |
| Market Cap (mil) | 13.78 |
| P/E | |
| Forward P/E |
| EPS | -0.02 |
| Avg earnings growth rate | -63.26% |
| TTM earnings | -3.17 |